Advances in Non-Viral DNA Vectors for Gene Therapy
AbstractUses of viral vectors have thus far eclipsed uses of non-viral vectors for gene therapy delivery in the clinic. Viral vectors, however, have certain issues involving genome integration, the inability to be delivered repeatedly, and possible host rejection. Fortunately, development of non-viral DNA vectors has progressed steadily, especially in plasmid vector length reduction, now allowing these tools to fill in specifically where viral or other non-viral vectors may not be the best options. In this review, we examine the improvements made to non-viral DNA gene therapy vectors, highlight opportunities for their further development, address therapeutic needs for which their use is the logical choice, and discuss their future expansion into the clinic View Full-Text
Share & Cite This Article
Hardee, C.L.; Arévalo-Soliz, L.M.; Hornstein, B.D.; Zechiedrich, L. Advances in Non-Viral DNA Vectors for Gene Therapy. Genes 2017, 8, 65.
Hardee CL, Arévalo-Soliz LM, Hornstein BD, Zechiedrich L. Advances in Non-Viral DNA Vectors for Gene Therapy. Genes. 2017; 8(2):65.Chicago/Turabian Style
Hardee, Cinnamon L.; Arévalo-Soliz, Lirio M.; Hornstein, Benjamin D.; Zechiedrich, Lynn. 2017. "Advances in Non-Viral DNA Vectors for Gene Therapy." Genes 8, no. 2: 65.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.